4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000065
EVP, Finance & CFO sold 12,922 shares at $75.22 ($971,993)
- EVP, Finance & CFO acquired 28,729 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HOUGEN ELIZABETH L · EVP, Finance & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form | +28,729 | 139,229 | D | ||
| 2026-01-16 | Sale : show line 2 in the form | −12,922 | $75.22 | $971,993 | 126,307 | D |
| Open-market sales · 12,922 sh · avg $75.22 · $971,993 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +34,360 | 120,995 | D |
| 2026-01-15 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −28,729 | 55,940 | D |
| 2026-01-15 | Grant or award : show line 5 in the form Restricted Stock Unit | +12,885 | 68,825 | D |
Loading xslF345X05/edgardoc.xml…